MSHMX
Price
$13.90
Change
-$0.18 (-1.28%)
Updated
Sep 4 closing price
Net Assets
3.9M
RGAGX
Price
$88.99
Change
-$0.09 (-0.10%)
Updated
Sep 4 closing price
Net Assets
342.42B
Interact to see
Advertisement

MSHMX vs RGAGX

MSHMX vs RGAGX Comparison Chart in %
View a ticker or compare two or three
VS
MSHMX vs. RGAGX commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHMX is a Hold and RGAGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 342B vs. MSHMX (3.9M). MSHMX (0.53) and RGAGX (0.51) have matching dividends . MSHMX was incepted earlier than RGAGX: MSHMX (6 years) vs RGAGX (17 years). MSHMX (6.28) is less costly to investors than RGAGX (0.29). MSHMX is a more actively managed with annual turnover of: 61.00 vs. RGAGX (32.00). RGAGX has a lower initial minimum investment than MSHMX: RGAGX (250) vs MSHMX (1000000). RGAGX annual gain was more profitable for investors over the last year : 3.70 vs. MSHMX (-9.93). RGAGX return over 5 years is better than : 14.93 vs. MSHMX (-15.14).
MSHMXRGAGXMSHMX / RGAGX
Total Expense Ratio0.850.29293%
Annual Report Gross Expense Ratio6.280.292,166%
Fund Existence6 years17 years-
Gain YTD6.75910.45165%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.9M342B0%
Annual Yield % from dividends0.530.51105%
Returns for 1 year-9.933.70-268%
Returns for 3 years7.4545.5616%
Returns for 5 years-15.1414.93-101%
Returns for 10 yearsN/A106.74-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIOLX30.270.15
+0.50%
Morgan Stanley Inst International Opp L
FEUIX33.250.10
+0.30%
Fidelity Advisor Glbl Capital Apprec I
FSCOX23.630.04
+0.17%
Fidelity International Small Cap Opp
SGPSX98.800.14
+0.14%
ProFunds Small Cap Growth Svc
JFNSX86.17-0.76
-0.87%
Janus Henderson Global Life Sciences S